The Administration shall: evaluate the regulations adopted by the Natalie M. LaPrade Medical Cannabis Commission in Title 10, Subtitle 62 of the Code of Maryland Regulations; and on or before July 1, 2023, adopt emergency regulations to: carry out the licensure requirements specified under this title; implement procedures related to cannabis applications, licenses, and registrations in accordance with this title; assist the Comptroller in the collection of taxes imposed on the sale of adult–use cannabis under § 11–104(k) of the Tax – General Article; implement inventory management and tracking that does not differentiate between adult–use or medical cannabis or cannabis products before the point of sale, except for products allowed by the Administration for sale only to patients and caregivers; and establish operating requirements for cannabis licensees or cannabis registrants, including requirements for: security, including lighting, physical security, video, and alarm requirements; safe and secure delivery, transport, and storage of cannabis; preventing the sale or diversion of cannabis and cannabis products to persons under the age of 21 years; and health and safety standards governing the cultivation, manufacture, testing, and dispensing of cannabis or cannabis products. The emergency regulations that the Administration is required to adopt under subsection (a) of this section shall: be supplemental to the medical cannabis regulations under Title 10, Subtitle 62 of the Code of Maryland Regulations; and notwithstanding any other law, remain in effect until the taking effect of nonemergency regulations adopted under subsection (c) of this section. On or before July 1, 2024, the Administration shall adopt nonemergency regulations to carry out this title. To the extent practicable, the Administration shall adopt regulations requiring cannabis licensees to transition from a cash system and to use traditional banking services. The Administration shall adopt regulations: governing Internet sales of cannabis; implementing and supplementing packaging and labeling requirements for cannabis products under § 36–203.1 of this subtitle; establishing procedures for the use of point of sale technologies by dispensaries for all transactions in order to verify a consumer’s age using a driver’s license or other valid identification issued by a governmental unit specified by the Administration; and establishing health, safety, security, and tracking requirements for the packaging and repackaging of cannabis by a dispensary in accordance with § 36–203.1 of this subtitle. The regulations adopted by the Administration under this section shall, to the extent practicable, regulate medical and adult–use cannabis in the same manner.